H-VQII^NK^-OH

Ref. 3D-PP41977

Informations sur le produit

• Nom: H-VQII^NK^-OH

Description

Peptide H-VQII^NK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VQII^NK^-OH include the following: Characterization of Two VQIXXK Motifs for Tau Fibrillization in Vitro W Li, VMY Lee - Biochemistry, 2006 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi061422+ Carbamylation promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils VG KrishnaKumar, L Baweja , K Ralhan - Biochimica et Biophysica , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304416518302393 Crystal structure of the human tau PHF core domain VQIINK complexed with the Fab domain of monoclonal antibody Tau2r3 T Tsuchida, K Susa, T Kibiki, T Tsuchiya - FEBS , 2020 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1002/1873-3468.13791 Structural study of the recognition mechanism of tau antibody Tau2r3 with the key sequence (VQIINK) in tau aggregation T Tsuchida, K Susa, T Kibiki, T Tsuchiya - Biochemical and , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X21015345 Antimicrobial, polarizing light, and paired helical filament properties of fragmented tau peptides of selected putative gingipains S Kanagasingam, C von Ruhland - Journal of , 2022 - content.iospress.comhttps://content.iospress.com/articles/journal-of-alzheimers-disease/jad220486 Structure-based inhibitors of tau aggregation PM Seidler , DR Boyer , JA Rodriguez , MR Sawaya - Nature , 2018 - nature.comhttps://www.nature.com/articles/nchem.2889 O2-02-03: DEVELOPMENT OF STRUCTURE-BASED INHIBITORS OF TAU AGGREGATION AND SEEDING P Seidler , D Eisenberg - Alzheimer's & Dementia, 2018 - Wiley Online Libraryhttps://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1016/j.jalz.2018.06.2647 Design and Synthesis of Biologically Relevant N-Heteroatom Substituted beta-Strand Peptidomimetics MP Sarnowski - 2021 - search.proquest.comhttps://search.proquest.com/openview/dea2e16cc6afeaaeef8805ab19b79e3c/1?pq-origsite=gscholar&cbl=18750&diss=y The role of the VQIVYK peptide in tau protein phosphorylation M Perez , I Santa-Maraca­a , E Tortosa - Journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1471-4159.2007.04834.x Potent Tau aggregation inhibitor D-peptides selected against Tau-repeat 2 using mirror image phage display M Malhis, S Kaniyappan , I Aillaud - , 2021 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cbic.202100287 Phosphorylation regulates fibrillation of an aggregation core peptide in the second repeat of microtubule-binding domain of human tau M Inoue, S Kaida, S Nakano, C Annoni - Bioorganic & medicinal , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0968089614006786 Hexameric Aggregation Nucleation Core Sequences and Diversity of Pathogenic Tau Strains L Wu, SS Madhavan, C Tan, B Xu - Pathogens, 2022 - mdpi.comhttps://www.mdpi.com/2076-0817/11/12/1559 Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine K Nadimidla , T Ismail, M Kanapathipillai - Biopolymers, 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.23024 Molecular dynamics simulations to investigate the stability and aggregation behaviour of the amyloid-forming peptide VQIVYK from tau protein JH Zhao, HL Liu, CK Chuang, KT Liu, WB Tsai - Molecular , 2010 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/08927022.2010.499147 A hydrophobic surface is essential to inhibit the aggregation of a tau-protein-derived hexapeptide J Zheng , AM Baghkhanian - Journal of the American , 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja310817d In vitro tau fibrillization: mapping protein regions I Santa-Maraca­a , M Perez , F Hernandez, V Muz - et Biophysica Acta (BBA , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0925443906001049 Modulation of tau protein aggregation using 'Trojan'sequences G Pandey , S Morla , S Kumar - Biochimica et Biophysica , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304416520300593 Lysine ε-aminolysis and incorporation of sulfhydryl groups into human brain tau 4R/1N and 306VQIVYK311 enhances the formation of beta structures and toxicity F Salmani , M Mohammadi, R Seif, SH Khatami - International Journal of , 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0141813024010262 Understanding the disrupting mechanism of the Tau aggregation motif"306VQIVYK311" by phenylthiazolyl-hydrazides inhibitors E Moreno-Castillo , YM acalvarez-Ginarte - Journal of Molecular , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jmr.2848 Integrating in vitro and in silico approaches to evaluate the"dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils E Haj, Y Losev, VG KrishnaKumar, E Pichinuk - et Biophysica Acta (BBA , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304416518300941 Tau local structure shields an amyloid-forming motif and controls aggregation propensity D Chen , KW Drombosky, Z Hou , L Sari - Nature , 2019 - nature.comhttps://www.nature.com/articles/s41467-019-10355-1 Peptides for disrupting and degrading amyloids CQ Liang, YM Li - Current Opinion in Chemical Biology, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1367593121000788 Simulations of Amyloid-Forming Peptides in the Crystal State AN Hosseini, D Van der Spoel - The Protein Journal, 2023 - Springerhttps://link.springer.com/article/10.1007/s10930-023-10119-3 The development of peptide-based inhibitors for Tau aggregation as a potential therapeutic for Alzheimer's disease AGA Aggidis - 2019 - search.proquest.comhttps://search.proquest.com/openview/1b6425cdbc87baf79d7e6648577e6ac8/1?pq-origsite=gscholar&cbl=18750&diss=y Thermodynamics and Aggregation Kinetics of Lysozyme-Derived Peptides AA Hakami Zanjani - 2019 - orbilu.uni.luhttps://orbilu.uni.lu/handle/10993/40678 Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6 A Dangi , AA Balmik , AK Ghorpade , NV Gorantla - RSC , 2020 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2020/ra/d0ra03809a Peptide-based inhibitors of Tau aggregation as a potential therapeutic for Alzheimer's disease and other Tauopathies A Aggidis , S Chatterjee, D Townsend, NJ Fullwood - bioRxiv, 2021 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2021.06.04.447069.abstract

• Marque: Biosynth